GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 812 filers reported holding GLAXOSMITHKLINE PLC in Q4 2020. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $369,000 | -11.5% | 8,482 | -23.5% | 0.05% | -8.8% |
Q3 2020 | $417,000 | -10.3% | 11,091 | -2.7% | 0.06% | -17.4% |
Q2 2020 | $465,000 | +3.6% | 11,400 | -3.8% | 0.07% | -14.8% |
Q1 2020 | $449,000 | -26.2% | 11,846 | -8.5% | 0.08% | +2.5% |
Q4 2019 | $608,000 | +27.5% | 12,946 | +36.1% | 0.08% | +79.5% |
Q3 2013 | $477,000 | -10.5% | 9,510 | -10.8% | 0.04% | -10.2% |
Q2 2013 | $533,000 | – | 10,661 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |